Skip to content
Open access

Biological aging, circulating lipid biomarkers and pancreatic diseases: a prospective cohort study based on the UK Biobank

Sep 2026 · The Journal of Nutrition, Health & Aging · Vol 30 · 0 citations · 56 references
Medicine

TL;DR

Ageing biomarkers, particularly in accelerated aging populations, are significantly associated with pancreatic disease risk, with potential implications for clinical risk stratification.

Abstract

Background Biological aging refers to gradual declines in overall physiological function and can raise susceptibility to diseases. However, whether biological age acceleration is associated with pancreatic diseases remains unclear. Methods In UK Biobank, 326,873 adults recruited in 2006–2010 were included. Klemera-Doubal Method Biological Age Acceleration (KDMAgeAccel) and Phenotypic Age Acceleration (PhenoAgeAccel) were categorized (G1–G4 by standard deviation [SD]) and modeled continuously. We examined the associations and dose-response relationships between acceleration and the following clinical outcomes: overall pancreatic diseases, acute pancreatitis, chronic pancreatitis, pancreatic cysts, pancreatic cancer, and pancreas-related mortality. Cohen’s d, independent t-tests, multivariable Cox proportional hazards regression, and causal mediation analysis were used to assess differences between aging groups, disease associations, and the mediation effects of circulating lipid biomarkers. Results KDMAgeAccel and PhenoAgeAccel demonstrated significant associations with pancreatic disease risk (both P < 0.05). PhenoAgeAccel demonstrated significant non-linear associations with overall pancreatic diseases, pancreatic cysts, pancreatic cancer, and pancreas-related mortality (all P for non-linearity <0.05), while no significant non-linearity was observed for acute pancreatitis or chronic pancreatitis (both P for non-linearity >0.05). In the fully adjusted Cox model, compared with G1, the PhenoAgeAccel G4 group had higher risks of all pancreatic diseases (hazard ratio [HR] 1.706, 95% confidence interval [CI] 1.513–1.923), acute pancreatitis (1.637, 1.352–1.981), chronic pancreatitis (3.551, 2.248–5.609), pancreatic cysts (1.547, 1.128–2.122), pancreatic cancer (1.387, 1.123–1.713), and pancreas-related mortality (1.442, 1.139–1.824).Circulating lipid biomarkers partially mediated the association between PhenoAgeAccel and pancreatic diseases, with notable contributions from free cholesterol in small LDL (6.66% for chronic pancreatitis), cholesterol to total lipids ratio in medium LDL (8.54% for acute pancreatitis), and cholesterol to total lipids ratio in large LDL (8.06% for pancreatic cancer). Conclusions Aging biomarkers, particularly in accelerated aging populations, are significantly associated with pancreatic disease risk, with potential implications for clinical risk stratification. Circulating lipid biomarkers were identified as potential statistical mediators of the association between PhenoAgeAccel and pancreatic diseases.

Read PDF

Similar papers

Review Aug 2026

Associations of biological aging and biological age acceleration with mortality in patients with cardiorenal syndrome: A prospective cohort study.

KDM-BA, KDM-BA, PhenoAge, KDM-BAA, and PhenoAgeAccel are significantly associated with all-cause mortality among the CRS population, with a non-linear relationship observed in cerebrovascular disease.

Xin-Tong Yang, Yu-Rong Zhang, Y. Zhong et al. · 0 citations
Review Sep 2026

Association between biological aging and premature mortality among patients with metabolic dysfunction-associated steatotic liver disease.

BACKGROUND Biological aging is a well-established risk factor for age-related diseases. However, its specific impact on patients with metabolic dysfunction-associated steatotic liver disease (MASLD) remains unclear. This study aimed to investigate the association between biological aging and premature mortality among p...

Song-Lin Li, Bao-Gang Chen · 0 citations
Open access Sep 2026

Proteomic signatures of systemic inflammation in aging, multimorbidity, and mortality.

PIS provides a compact, interpretable proteomic measure of inflammaging and captures mortality, multisystem disease burden, and aging-related biology in population-scale cohorts.

Zhou Jiang, Dan-Yang Ling, Zi-Wei Chen et al. · 0 citations
Open access Sep 2026

A Pathology-Trained Lipid Aging Clock Reveals Accelerated Aging and Prognostic Sphingolipid Signatures in Pancreatic Disease.

A lipid-based biological aging clock developed from serum lipidomics data of 443 patients with pancreatic ductal adenocarcinoma was associated with pancreatic disease and with lipidomic patterns consistent with systemic aging-associated and inflammatory remodeling independent of traditional oncological risk parameters.

M. Unfried, A. Cazenave-Gassiot, E. Bischof et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.